---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-25-000012"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T01:24:24.349152+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q1 Adj EPS $2.25 vs $1.31 YoY; raises FY25 Adj EPS guidance to $6.00-$6.20

## Summary
- Total revenues $94.6B, up 7.0% YoY; GAAP diluted EPS $1.41, Adjusted EPS $2.25.
- Operating income $3.374B vs $2.271B YoY; adjusted operating income $4.579B vs $2.957B.
- Full-year 2025 guidance: GAAP diluted EPS revised to $4.23-$4.43 from $4.58-$4.83; Adjusted EPS raised to $6.00-$6.20 from $5.75-$6.00.
- CVS Health to exit individual exchange business; introduces Aetna solutions and CVS Caremark GLP-1 formulary update.
- Cash flow from ops $4.6B in Q1; FY25 CF guidance raised to ~$7.0B from ~$6.5B.

## SEC filing metadata
- accession: 0000064803-25-000012
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/0000064803-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480325000012/cvs-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-25-000012
- JSON: https://secwatch.observer/filing/0000064803-25-000012.json
- Plain text: https://secwatch.observer/filing/0000064803-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.